Watch Godavari Biorefineries Limited for free: we tell you when fair value or trend changes.

Godavari Biorefineries Limited (GODAVARIB) fair value: what the stock is really worth

As of Oct 26, 2026: fair value (intrinsic value) of Godavari Biorefineries Limited stock ₹20.71, price ₹197, upside -89.5%, quality 37 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials · IN

Thin data Oct 26, 2026

Godavari Biorefineries Limited

GODAVARIB · NSE

Weakest SetupStrongly overvalued and low quality.

Our calculation puts a fair price 89% below what the stock costs today.

Low debt

Expensive Growth (revenue 5y +5.3 %/yr in INR)

Thin margins · 0.0% net margin (TTM)

Fair value ₹20.71 · Strongly overvalued (−89.5%)

Quality 37/100

Negative free cash flow

Trails peers (1/11)

Narrow moat 19/100 · thin data

Thin data

Structural break⟳ Cyclical⚠ Dilution

26 models, one by oneBear ₹14.41 to bull ₹25.63 Growth analysisrevenue history, year by year Quality 37/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Godavari Biorefineries Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 26, 2026.

How to read this chart

24‑month range ₹147.36 – ₹393.25 · fair‑value band ₹14.41 – ₹25.63 · the ₹197.03 price screens above the ₹20.71 fair value. Dashed = 300-day average. As of Oct 26, 2026.

Follow Godavari Biorefineries in your weekly email

Every Wednesday you see whether Godavari Biorefineries is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Godavari Biorefineries Limited manufactures and sells sugar in India. It provides distillery, including ethanol, bio-chemicals, and other bio products; and classic and brown sugar, plantation white sugar, and refined sugar.

Show moreShow less

The company also offers perfumery and pharmaceutical grade ethanol, rectified spirits, anhydrous alcohol, and extra neutral alcohol; hand sanitizers; sugarcane wax; and sugarcane concentrate, jaggery, turmeric, and sea salt, as well as produces electricity through the generation of steam and power produced from biomass.

In addition, it provides biobased acetic acid; biobased ethyl acetate; biobased butanol; ethyl acetate; 1,3 butylene glycol; 2-ethyl-1,3 hexanediol; 3 -methyl- 3- penten -2 -one; 3-methoxy butanol; acetaldehyde; acetaldehyde diethyl acetal; crotonaldehyde; crotonic anhydride; crotononitrile; crotonaldehyde; ethyl crotonate; ethyl 3-amino crotonate; ethyl lactate; methyl crotonate; paraldehyde; perfumery material base; sodium sulphate; 2-ethyl butanol; naturo butyl acetate; naturoSORBAL; SOMFROTH; and ethyl vinyl ether.

The company serves adhesive and lubricant, biofuel, electronic, flavor, food and beverage, fragrance, oil and gas, mining, packaging and printing ink, paint and coating, personal care and cosmetic, pharmaceutical, plastics, paper, resin, textile, and leather industries.

The company was formerly known as Godavari Investment and Finance Corporation Limited and changed its name to Godavari Biorefineries Limited in January 2006. Godavari Biorefineries Limited was founded in 1939 and is based in Mumbai, India.

Stock analysis

Godavari Biorefineries Limited (GODAVARIB) currently trades at ₹197.03, while our model-based Fair Value estimate is ₹20.71, 89.5% below the price, so the stock looks overvalued today.

Valuation

Bull case: the Asset-Based group reads highest at a median of ₹100.61 per share, and 1 of the 14 models we run sit above the ₹197.03 price.

Bear case: the Earnings-Based group reads lowest at ₹3.76, and 13 of the 14 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹14.41 (bear) to ₹25.63 (bull), the price of ₹197.03 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Godavari Biorefineries Limited reported revenue of ₹19.9B in FY2026 versus ₹17.0B in FY2022, a compound +4.0%/yr. Reported net income was ₹35.3M in FY2026, compounding −34.4%/yr from FY2022.

Key figures

Market cap ₹11.7B (≈ $123M) Micro · P/S ratio 0.58 · EPS (TTM) ₹0.0500 · Net margin 0.0% · Return on equity 0.5% · Return on assets (EBIT) 4.2% · Operating margin −2.5% · Revenue (TTM) ₹20.1B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (low confidence).

What moves the price

The share trades about 41% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −35% fair-value upside, at −89%, GODAVARIB screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (₹3.76 to ₹450.48). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.

Bear ₹14.41 Fair Value ₹20.71 Bull ₹25.63

Price ₹197.03 · Upside -89.5%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹0.0288 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

EPV ₹16.95 ₹24.36 ₹30.15 73

ROIC Compounder ₹16.95 ₹24.36 ₹30.15 72

Residual Income ₹85.53 ₹73.14 ₹64.85 71

All 14 models by family

Earnings-Based

Graham-Dodd ₹4.69 ₹13.09 ₹17.21 65

Lynch FV ₹2.63 ₹3.76 ₹4.89 61

PEG = 1.0 ₹2.63 ₹3.76 ₹4.89 57

EPV ₹16.95 ₹24.36 ₹30.15 73

Multiples

P/E Multiple ₹8.79 ₹11.72 ₹14.65 63

P/S Multiple ₹8.79 ₹11.72 ₹14.65 58

P/B Multiple ₹337.86 ₹450.48 ₹563.10 55

EV/EBIT ₹51.58 ₹101.25 ₹150.92 63

EV/EBITDA ₹88.86 ₹150.96 ₹213.06 65

EV/Revenue ₹31.71 ₹87.06 ₹142.40 50

Asset-Based

NCAV (Graham) ₹75.08 ₹100.61 ₹150.16 54

Economic Profit

Residual Income ₹85.53 ₹73.14 ₹64.85 71

ROIC Compounder ₹16.95 ₹24.36 ₹30.15 72

Growth Earnings

Growth-Adj P/E ₹7.16 ₹10.23 ₹13.30 67

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 37/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 31

How much profit the company makes from its sales and capital

Quality Growth 54

Are margins and returns getting better?

Cashflow 35

Do the profits arrive as real cash?

Financial strength 34

Debt, balance sheet and risk of trouble

Investment 50

Does it invest with discipline instead of growing at any price?

Low Volatility 36

How calm the share price moves, does not count

Momentum 13

Price trend of the last 3 to 12 months, does not count

Near the 52-week high 3

Distance to the 52-week high, does not count

New shares 42

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

+6.3%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−0.4%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+5.3%

Start year 2021 (pandemic)

Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+6.2%

’18

’19

’20

’21

’22

’23

’24

’25

’26

What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.

−3.7%

Earnings growth per share plus dividend.

Earnings per share, growth per year−3.7%

Dividend (yield on the price)0.0%

Profit margin 2020 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 4%

GODAVARIB screens overvalued: fair value 89% below the price. Compare with Saudi Basic Industries Corporation →

Compare Godavari Biorefineries Limited with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 339 stocks

Beats the industry median on 1/11 measures

Overall it trails its industry peers.

Valuation

Quality Score 37 · Bottom 25%

Fair Value upside −89.5% · Bottom 25%

Profitability

Return on equity (12 months) 0.5% · Below median

Return on assets 0.2% · Below median

Net margin (12 months) 0.0% · Bottom 25%

Operating margin (12 months) −2.5% · Bottom 25%

Growth and dividend

Revenue growth (quarter YoY) 4.6% · Below median

Balance sheet

Debt / equity 0.42× · Highest 25%

Valuation Multiplesvs Chemicals median · lower = cheaper

P/B 1.48× · Pricier than median

P/S (12 months) 0.58× · Cheapest 25%

EV/EBITDA 12.0× · Pricier than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 10

FUTURE (revenue growth)23 · sector 63

PAST (return on equity)2 · sector 23

HEALTH (low debt)79 · sector 94

DIVIDEND (yield)0 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Hengli Petrochemical Co 600346	¥15.22	¥43.28	+184%	vs GODAVARIB
LG Chem, Ltd 051910	255,500 KRW	587,755 KRW	+130%	vs GODAVARIB
Ningxia Baofeng Energy Group 600989	¥22.18	¥40.44	+82%	vs GODAVARIB
Zangge Mining Company 000408	¥67.22	¥73.94	+10%	vs GODAVARIB
Zhejiang Juhua Co 600160	¥29.72	¥19.31	−35%	vs GODAVARIB
Dow Inc DOW	$32.61	$20.98	−36%	vs GODAVARIB
Saudi Basic Industries Corporation 2010	43.72 SAR	24.66 SAR	−44%	vs GODAVARIB
Jiangsu Eastern Shenghong Co 000301	¥12.13	¥3.06	−75%	vs GODAVARIB
Formosa Chemicals & Fibre Corporation 1326	76.20 TWD	17.66 TWD	−77%	vs GODAVARIB
Rongsheng Petrochemical Co 002493	¥11.63	¥2.39	−79%	vs GODAVARIB

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Godavari Biorefineries Limited · Fair Value
₹20.71 −89%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/GODAVARIB" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Godavari Biorefineries Limited · Fair Value</span><br><b style="font-size:20px">₹20.71</b> <span style="color:var(--red);font-weight:700;font-size:14px">−89%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Godavari Biorefineries Limited Fair Value". https://www.fairvalue-calculator.com/stock/GODAVARIB

Frequently asked questions

Is Godavari Biorefineries Limited (GODAVARIB) overvalued or undervalued?

As of Oct 26, 2026, our model estimates a fair value of ₹20.71 versus a price of ₹197.03, about −89% upside (overvalued).

What is the fair value of GODAVARIB?

Our model-based fair value for Godavari Biorefineries Limited is ₹20.71 (as of Oct 26, 2026), built from audited fundamentals. The current price: ₹197.03.

What is the quality score of GODAVARIB?

Godavari Biorefineries Limited has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Godavari Biorefineries Limited (GODAVARIB)?

Our model-based price target is the fair value of ₹20.71 (as of Oct 26, 2026) from 14 valuation models. Cautious scenario ₹14.41, optimistic scenario ₹25.63. It is a calculation from audited fundamentals, not an analyst target.

What is the Godavari Biorefineries Limited stock forecast for 2026?

Our models put fair value at ₹20.71, about −89% upside versus a price of ₹197.03 (overvalued). Cautious scenario ₹14.41, optimistic scenario ₹25.63. The calculation is refreshed regularly with new filings.

What is the revenue of Godavari Biorefineries Limited (GODAVARIB)?

Godavari Biorefineries Limited reported trailing-twelve-month revenue of about ₹20.1B (latest available figure, as of Oct 26, 2026).

What is the intrinsic value of Godavari Biorefineries Limited (GODAVARIB)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Godavari Biorefineries Limited it is ₹20.71 per share (as of Oct 26, 2026), against a price of ₹197.03. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).

Is Godavari Biorefineries Limited stock overvalued or undervalued in 2026?

As of Oct 26, 2026, GODAVARIB trades above its calculated fair value: price ₹197.03, fair value ₹20.71, a gap of about −89% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of GODAVARIB?

No. The price is what the market pays today (₹197.03); the fair value is what the company's own numbers justify (₹20.71). For Godavari Biorefineries Limited the two are ₹176.32 per share apart. That gap is exactly why we show both numbers side by side.

How much is Godavari Biorefineries Limited worth?

The market values Godavari Biorefineries Limited at about ₹11.7B (market capitalisation, as of Oct 26, 2026). Per share that is ₹197.03; our models calculate a fair value of ₹20.71 per share.

What do the bullish and bearish scenarios say about GODAVARIB?

Our models span a range for Godavari Biorefineries Limited: cautious scenario ₹14.41, base ₹20.71, optimistic ₹25.63 per share (as of Oct 26, 2026, price ₹197.03). The range comes from different growth and margin assumptions, not from analyst opinions.

How solid is the balance sheet of Godavari Biorefineries Limited (GODAVARIB)?

Balance-sheet figures for Godavari Biorefineries Limited (as of Oct 26, 2026): return on equity 0.5%, debt of 0.42 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.

How far is GODAVARIB from its 52-week high?

Godavari Biorefineries Limited trades at ₹197.03, about 41% below its 52-week high of ₹334.90 and at the low of ₹197.03 (as of Oct 26, 2026). Distance from the high says nothing about value: that is what the fair value of ₹20.71 is for.

Which stocks are comparable to Godavari Biorefineries Limited?

From the same area (Basic Materials) we also value Saudi Basic Industries Corporation, Ningxia Baofeng Energy Group, Dow Inc, Rongsheng Petrochemical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Godavari Biorefineries Limited stock attractive at the current price?

The data as of Oct 26, 2026: price ₹197.03, calculated fair value ₹20.71 (−89%), Quality Score 37/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of GODAVARIB calculated?

We run Godavari Biorefineries Limited through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹20.71, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 12.7 % above its aggregate fair value. Godavari Biorefineries Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Godavari Biorefineries Limited (GODAVARIB)?

The closing price on Oct 26, 2026 was ₹197.03. Our model-based fair value is ₹20.71, about −89% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Godavari Biorefineries Limited right now?

The price sits above even our optimistic bull case (₹25.63). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Godavari Biorefineries Limited

How large is the market capitalisation of Godavari Biorefineries Limited (GODAVARIB)?

The market capitalisation of Godavari Biorefineries Limited is ₹11.7B (≈ $123M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Godavari Biorefineries Limited (GODAVARIB)?

The price-to-sales ratio of Godavari Biorefineries Limited is 0.58 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Godavari Biorefineries Limited (GODAVARIB)?

Earnings per share at Godavari Biorefineries Limited are ₹0.0500. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Godavari Biorefineries Limited (GODAVARIB)?

The net margin of Godavari Biorefineries Limited is 0.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Godavari Biorefineries Limited (GODAVARIB)?

The return on equity (ROE) of Godavari Biorefineries Limited is 0.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Godavari Biorefineries Limited (GODAVARIB)?

On an EBIT basis the return on assets of Godavari Biorefineries Limited is 4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Godavari Biorefineries Limited (GODAVARIB)?

The operating margin of Godavari Biorefineries Limited is −2.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Godavari Biorefineries Limited (GODAVARIB)?

Revenue at Godavari Biorefineries Limited is growing +4.6% versus a year earlier (3y avg −0.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Godavari Biorefineries Limited (GODAVARIB)?

Earnings per share at Godavari Biorefineries Limited are growing −26.5% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does Godavari Biorefineries Limited (GODAVARIB) generate?

The free cash flow of Godavari Biorefineries Limited is −₹447M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does Godavari Biorefineries Limited (GODAVARIB) carry?

The net debt of Godavari Biorefineries Limited is ₹5.0B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Godavari Biorefineries Limited in the live analysis

One click puts Godavari Biorefineries Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.